The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Sertraline treatment of panic disorder: results of a long-term study
Abstract
Objective: To investigate the long‐term efficacy, prevention of relapse and safety of sertraline in the treatment of panic disorder. Method: This study consisted of 52 weeks of open‐label sertraline treatment (n=398) followed by a 28 weeks of a double‐blind, placebo‐controlled discontinuation trial (n=183). Results: Ninety‐three patients were randomized to sertraline and 90 were randomized to placebo. Discontinuation due to insufficient clinical response occurred in 23.6% of placebo‐treated patients and 12.0% of sertraline‐treated patients (log‐rank test, P=0.040). Thirty‐three per cent of placebo‐treated patients had an exacerbation of panic symptomatology, versus 13% of sertraline‐treated patients (log‐rank test, P=0.005). Abrupt cessation of sertraline resulted in dizziness (4.3% sertraline vs. 16.9% placebo; P=0.007) and insomnia (4.3% sertraline vs. 15.7% placebo; P=0.013) occurring at significantly higher rates. Conclusion: Long‐term sertraline treatment was effective in preventing relapse of panic disorder, well tolerated and associated with minimal discontinuation symptoms.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Twelve studies included antidepressants for depressive disorder, and one study included antidepressants for panic disorder with or without agoraphobia (Rapaport 2001).”
From Approaches for discontinuation versus continuation of long-term antidepressant use for depressive and anxiety disorders in adults (2021) · cites this paper as Rapaport 2001
In the citing paper
“Study authors reported no difference in depression between the discontinuation group (9/89; 10.1%) and the continuation group (9/92; 9.8%) (P = 1) (Rapaport 2001).”
From Approaches for discontinuation versus continuation of long-term antidepressant use for depressive and anxiety disorders in adults (2021) · cites this paper as Rapaport 2001
In the citing paper
“All studies measured relapse of depression except one, which reported relapse of panic disorder in participants with panic disorder (Rapaport 2001).”
From Approaches for discontinuation versus continuation of long-term antidepressant use for depressive and anxiety disorders in adults (2021) · cites this paper as Rapaport 2001
In the citing paper
“Mean change from baseline to 28 weeks on the HAM-A Scale for participants with panic disorder was 3.95 (SD 7.35) in the discontinuation group (n = 89) and 1.65 (SD 7.01) in the antidepressant group (n = 92).Study authors reported no differences between groups (P = 0.154; P value obtained from (ANCOVA) model, with treatment, site, and baseline values as effects).”
From Approaches for discontinuation versus continuation of long-term antidepressant use for depressive and anxiety disorders in adults (2021) · cites this paper as Rapaport 2001
Citations
Cites
The assessment of anxiety states by rating
HAMILTON, M. (1959) · British Journal of Medical Psychology · doi:10.1111/j.2044-8341.1959.tb00467.x · Cited by 11,455
(1993) · PubMed · Cited by 1,900
Comprehensive Textbook of Psychiatry
Schwab, J. J. (1968) · Psychosomatics · doi:10.1016/s0033-3182(68)71813-2 · Cited by 1,294
Multicenter Collaborative Panic Disorder Severity Scale
Shear, M. K., Brown, T. A., Barlow, D. H., Money, R., Sholomskas, D. E., Woods, S. W., Gorman, J. M., & Papp, L. A. (1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.11.1571 · Cited by 1,001
Barlow, D. H., Gorman, J. M., Shear, M. K., & Woods, S. W. (2000) · JAMA · doi:10.1001/jama.283.19.2529 · Cited by 953
Ormel, E. A. (1995) · PsycEXTRA Dataset · doi:10.1037/e536912011-072 · Cited by 706
Clark, D. M., Salkovskis, P. M., Hackmann, A., Middleton, H., Anastasiades, P., & Gelder, M. (1994) · British Journal of Psychiatry · doi:10.1192/bjp.164.6.759 · Cited by 673 · cited 1×
“By contrast, in discontinuation studies where cognitive-behavioral therapy is compared with imipramine treatment, the rate of exacerbation of panic disorder symptomatology was lower for patients assigned to CBT (36, 37).”
ResultQuality of Life in Panic Disorder
Markowitz, J. S. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810110026004 · Cited by 468
Long-term Therapeutic Use of Benzodiazepines: I. Effects of Abrupt Discontinuation
Rickels, K. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810220015002 · Cited by 332
Panic attacks in the community. Social morbidity and health care utilization
Klerman, G. L. (1991) · JAMA · doi:10.1001/jama.265.6.742 · Cited by 286
Paroxetine in the Treatment of Panic Disorder a Randomised, Double-Blind, Placebo-Controlled Study
Oehrberg, S., Christiansen, P. E., Behnke, K., Borup, A. L., Severin, B., Soegaard, J., Calberg, H., Judge, R., Ohrstrom, J. K., & Manniche, P. M. (1995) · British Journal of Psychiatry · doi:10.1192/bjp.167.3.374 · Cited by 261
Outcome of Panic Disorder: Relationship to Diagnostic Subtypes and Comorbidity
Noyes, R. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810210017003 · Cited by 197
Long-term Therapeutic Use of Benzodiazepines: II. Effects of Gradual Taper
Schweizer, E. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810220024003 · Cited by 191
Quality of Life Enjoyment and Satisfaction Questionnaire
Endicott, J., Nee, J., Harrison, W., & Blumenthal, R. (2016) · PsycTESTS Dataset · doi:10.1037/t49981-000 · Cited by 188
McTavish, D., & Benfield, P. (1990) · Drugs · doi:10.2165/00003495-199039010-00010 · Cited by 161
Sertraline in the Treatment of Panic Disorder
Pollack, M. H., Otto, M. W., Worthington, J. J., Manfro, G. G., & Wolkow, R. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.11.1010 · Cited by 143
Self-citationLong‐term evaluation of paroxetine, clomipramine and placebo in panic disorder
Lecrubier, Y., Judge, R., & The Collaborative Paroxetine Panic Study Investigators (1997) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1997.tb00389.x · Cited by 139
Sertraline in the Treatment of Panic Disorder: A Double-Blind Multicenter Trial
Pohl, R. B., Wolkow, R., & Clary, C. M. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.9.1189 · Cited by 134
Self-citationPanic disorder and quality of life: variables predictive of functional impairment
Hollifield, M. A., Katon, W. J., SKIPPER, B. J., Chapman, T., Ballenger, J. C., Mannuzza, S., & Fyer, A. J. (1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.6.766 · Cited by 130
Schweizer, E. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820130053009 · Cited by 120
A Controlled, Prospective, 1-Year Trial of Citalopram in the Treatment of Panic Disorder
Lepola, U. M., Wade, A. G., Leinonen, E. V. J., Koponen, H., Frazer, J., Sjödin, I., Penttinen, J., Pedersen, T., & Lehto, H. (1998) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v59n1006 · Cited by 111
Outcome of panic and depression in a seven‐year follow‐up: results of the Zurich study
Volirath, M., & Angst, J. (1989) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1989.tb03031.x · Cited by 108
Maintenance Drug Treatment for Panic Disorder
Rickels, K. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820130067010 · Cited by 94
Noyes, R., Garvey, M. J., Cook, B. L., & Samuelson, L. (1989) · PubMed · Cited by 94
The Longitudinal Course and Outcome of Panic Disorder
Pollack, M. H., & Smoller, J. W. (1995) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(18)30023-6 · Cited by 63
Self-citationWithdrawal phenomena associated with antidepressant and antipsychotic agents
Dilsaver, S. C. (1994) · Drug Safety · doi:10.2165/00002018-199410020-00002 · Cited by 60
Michelson, D., Pollack, M. H., Lydiard, R. B., Tamura, R., Tepner, R. G., Tollefson, G. D., & The Fluoxetine Panic Disorder Study Group (1999) · The British Journal of Psychiatry · doi:10.1192/bjp.174.3.213 · Cited by 56
Self-citationSchweizer, E. E., Patterson, W. M., Rickels, K., & Rosenthal, M. (1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.8.1210 · Cited by 45
Maintenance drug therapy of panic disorder
Curtis, G. C., Massana, J., Udina, C., Ayuso, J. L., Cassano, G. B., & Perugi, G. (1993) · Journal of Psychiatric Research · doi:10.1016/0022-3956(93)90023-u · Cited by 42
The Galway Study of Panic Disorder III
O'Rourke, D., Fahy, T. J., Brophy, J., & Prescott, P. (1996) · The British Journal of Psychiatry · doi:10.1192/bjp.168.4.462 · Cited by 41
Gauging the Effectiveness of Extended Imipramine Treatment for Panic Disorder with Agoraphobia
MAVISSAKALIAN, M. R., Perel, J. M., Talbott-Green, M., & Sloan, C. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00376-4 · Cited by 39
Long‐Term Outcome of Panic Disorder Treatment: A Review of the Literature
Milrod, B., & Busch, F. (1996) · Journal of Nervous and Mental Disease · doi:10.1097/00005053-199612000-00002 · Cited by 37
Treatment of Panic Disorder: A Consensus Development Conference
Jarrett, F. (1995) · Psychiatric Services · doi:10.1176/ps.46.4.413 · Cited by 34
Panic disorder as a chronic illness.
Liebowitz, M. R. (1997) · PubMed · Cited by 30
ON THE TREATMENT OF PANIC DISORDER
Nishizono, M. (1994) · IX World Congress of Psychiatry · doi:10.1142/9789814440912_0139 · Cited by 18
The long-term efficacy and safety of paroxetine in panic disorder
Judge, R., & Steiner, M. (1996) · European Neuropsychopharmacology · doi:10.1016/0924-977x(96)88273-3 · Cited by 13
Judge, R., Burnham, D. B., STEINER, M., et al. (1996) · European Neuropsychopharmacology · doi:10.1016/0924-977x(96)83858-2 · Cited by 7
Rapaport, M. H., Frevert, T., Babior, S., Seymour, S., Zisook, S., Kelsoe, J. R., & Judd, L. L. (1996) · Anxiety · doi:10.1002/(sici)1522-7154(1996)2:3<145::aid-anxi6>3.0.co;2-o · Cited by 6
Self-citationRapaport, M. H., Frevert, T., Babior, S., Seymour, S., Zisook, S., Kelsoe, J. R., & Judd, L. L. (1996) · Anxiety · Cited by 6
Self-citation
Research works printed but not linked: 6
- Maser JD, 1994, Treatment of panic disorder
- Spitzer RL, 1987, Instruction manual for the Structured Clinical Interview for DSM‐III‐R
- Sheehan DV, 1989, Compre‐hensive textbook of psychiatry
- 10.1111/j.2044-8341.1959.tb00467.x · DOI · Paper page
- Guy W, 1976, ECDEU Assessment manual for psychopharmacology, revised
- 10.1002/(sici)1522-7154(1996)2:3<117::aid-anxi2>3.0.co;2-m · doi:10.1002/(sici)1522-7154(1996)2:3<117::aid-anxi2>3.0.co;2-m
Cited by
Bandelow, B., Zohar, J., Hollander, E., Kasper, S., Möller, H.-J., WFSBP TASK FORCE ON TREATMENT GUIDE, Bandelow, B., Zohar, J., Hollander, E., Kasper, S., et al. (2008) · The World Journal of Biological Psychiatry · doi:10.1080/15622970802465807 · Cited by 854
Baldwin, D. S., Anderson, I. M., Nutt, D. J., Bandelow, B., Bond, A., Davidson, J. R. T., den Boer, J. A., Fineberg, N. A., Knapp, M., Scott, J., et al. (2005) · Journal of Psychopharmacology · doi:10.1177/0269881105059253 · Cited by 617
Zhai, B., Wu, C., Wang, L., Sachs, M. S., & Lin, X. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00212-12 · Cited by 205
“In addition, abundant clinical data support the safety of long-term use of this antidepressant (6, 28, 29).”
BackgroundHeuzenroeder, L., Donnelly, M., Haby, M. M., Mihalopoulos, C., Rossell, R., Carter, R., Andrews, G., & Vos, T. (2004) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/j.1440-1614.2004.01423.x · Cited by 164
Batelaan, N. M., Bosman, R. C., Muntingh, A., Scholten, W. D., Huijbregts, K. M., & van Balkom, A. J. L. M. (2017) · BMJ · doi:10.1136/bmj.j3927 · Cited by 153
Metadata
- Authors
- Rapaport, M. H., Wolkow, R., Rubin, A., Hackett, E., Pollack, M., & Ota, K. Y.
- Affiliations
- University of California San Diego (US)
- Corresponding author
- Rapaport, Mark Hyman
- Venue
- Acta Psychiatrica Scandinavica
- Publisher
- Wiley
- Published
- 2001-10
- Volume
- 104
- Issue
- 4
- Pages
- 289-298
- ISSN
- 0001-690X (ISSN-L)
- 1600-0447
- OpenAlex
- W2093819587
- Semantic Scholar
- da024c2e90f2c72ed2b10174884d023c9386e27f
- Cited by
- 79
- References
- 39
- Citations by year
- 2025: 2 · 2024: 4 · 2023: 2 · 2022: 1 · 2021: 1 · 2020: 4 · 2019: 1 · 2017: 1 · 2016: 1 · 2015: 2 · 2014: 2 · 2013: 4 · 2012: 3
- FWCI
- 5.50
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Acta Psychiatrica Scandinavica (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
- Keywords
- sertraline, panic disorder, long-term treatment, relapse prevention, drug discontinuation, adverse effects, dizziness, insomnia, selective serotonin reuptake inhibitors
- MeSH terms
- Adult, Agoraphobia, Dose-Response Relationship, Drug, Double-Blind Method, Drug Administration Schedule, Female, Humans, Long-Term Care, Male, Middle Aged, Recurrence, Substance Withdrawal Syndrome, Panic Disorder, Treatment Outcome, Sertraline
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.